Reported Earnings • 21h
Full year 2026 earnings: EPS exceeds analyst expectations Full year 2026 results: EPS: ₹63.72 (down from ₹65.55 in FY 2025). Revenue: ₹20.6b (up 1.4% from FY 2025). Net income: ₹2.87b (down 3.3% from FY 2025). Profit margin: 14% (in line with FY 2025). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 7.6%. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 19% per year, which means it is tracking significantly ahead of earnings growth. Announcement • 22h
Dhanuka Agritech Limited announces Annual dividend, payable on September 02, 2026 Dhanuka Agritech Limited announced Annual dividend of INR 2.0000 per share payable on September 02, 2026, ex-date on July 17, 2026 and record date on July 17, 2026. Announcement • May 19
Dhanuka Agritech Limited, Annual General Meeting, Aug 03, 2026 Dhanuka Agritech Limited, Annual General Meeting, Aug 03, 2026, at 11:00 Indian Standard Time. Announcement • May 14
Dhanuka Agritech Limited to Report Q4, 2026 Results on May 19, 2026 Dhanuka Agritech Limited announced that they will report Q4, 2026 results on May 19, 2026 Price Target Changed • Feb 06
Price target decreased by 13% to ₹1,426 Down from ₹1,638, the current price target is an average from 8 analysts. New target price is 36% above last closing price of ₹1,051. Stock is down 29% over the past year. The company is forecast to post earnings per share of ₹59.12 for next year compared to ₹65.55 last year. Announcement • Feb 05
Dhanuka Agritech Limited Announces Board and Board Committee Changes The board of directors of Dhanuka Agritech Limited meeting held on February 5, 2026, Mr. Sachin Kumar Bhartiya (DIN: 00122147) will cease to be a Director of the Company upon completion of his second term of 5 years, at the close of business hours on February 8, 2026, with effect from 9 February, 2026. The board approved appointment of Mr. Sanjiv Goel (DIN: 03616090) as an Additional Director designated as Non-Executive Independent Director. Mr. Sanjiv Goel has been appointed as an Additional Director (independent), till the next general meeting or for a period of three months from the date of appointment, whichever is earlier; and further as an Independent Director for a tenure of 5 consecutive years commencing from 5 February, 2026 to 4h February, 2031, subject to the approval of the Members of the Company via Postal Ballot. Mr. Sanjiv Goel is an experienced business leader and advisor with over about 40 years of experience in techno-commercial roles, customer-centric operations, and strategic management across diverse industries. He has held senior leadership positions and has been actively involved in providing strategic advisory and consulting services to organizations. He is the Promoter of Profectus Solutions, a boutique consulting firm, and has been associated as a Partner /Advisor with various business groups, contributing to strategy formulation, business transformation, and governance advisory. Further he is also member of WIL group and group advisor at Blue Ocean Steel. His professional journey reflects deep exposure to corporate management, business advisory, and stakeholder engagement. With his extensive experience and strategic perspective, Mr. Goel brings valuable insights into business operations, governance practices, and long-term value creation, which will strengthen the Board's deliberations and oversight as an Independent Director. The Board of Directors of the company on February 5, 2026 have reconstituted the Audit Committee and Nomination and Remuneration Committee of the Board. Audit Committee: Mr. Satish Kumar Gupta- Chairman, Mr. Sanjay Saxena, Mr. Bajrang Lal Bajaj, Mr. Mahendra Kumar Dhanuka- members; Nomination & Remuneration Committee: Mr. Sanjay Saxena- Chairman, Mr. Bajrang Lal Bajaj and Mr. Satish Kumar Gupta- members. Announcement • Jan 30
Dhanuka Agritech Limited to Report Q3, 2026 Results on Feb 05, 2026 Dhanuka Agritech Limited announced that they will report Q3, 2026 results at 9:15 AM, Indian Standard Time on Feb 05, 2026 Price Target Changed • Nov 10
Price target decreased by 9.3% to ₹1,689 Down from ₹1,863, the current price target is an average from 8 analysts. New target price is 28% above last closing price of ₹1,319. Stock is down 19% over the past year. The company is forecast to post earnings per share of ₹62.94 for next year compared to ₹65.55 last year. Reported Earnings • Nov 01
Second quarter 2026 earnings released: EPS: ₹20.85 (vs ₹25.83 in 2Q 2025) Second quarter 2026 results: EPS: ₹20.85 (down from ₹25.83 in 2Q 2025). Revenue: ₹6.05b (down 7.6% from 2Q 2025). Net income: ₹939.7m (down 20% from 2Q 2025). Profit margin: 16% (down from 18% in 2Q 2025). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 24% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Oct 16
Dhanuka Agritech Limited to Report Q2, 2026 Results on Oct 31, 2025 Dhanuka Agritech Limited announced that they will report Q2, 2026 results on Oct 31, 2025 Buy Or Sell Opportunity • Oct 16
Now 21% overvalued Over the last 90 days, the stock has fallen 20% to ₹1,403. The fair value is estimated to be ₹1,162, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 9.6% over the last 3 years. Earnings per share has grown by 13%. Revenue is forecast to grow by 35% in 2 years. Earnings are forecast to grow by 28% in the next 2 years. New Risk • Aug 01
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Announcement • Jul 25
Dhanuka Agritech Limited to Report Q1, 2026 Results on Aug 01, 2025 Dhanuka Agritech Limited announced that they will report Q1, 2026 results on Aug 01, 2025 Upcoming Dividend • Jul 11
Upcoming dividend of ₹2.00 per share Eligible shareholders must have bought the stock before 18 July 2025. Payment date: 31 August 2025. Payout ratio is a comfortable 3.1% and this is well supported by cash flows. Trailing yield: 0.1%. Lower than top quartile of Indian dividend payers (1.2%). Lower than average of industry peers (0.7%). Reported Earnings • Jul 09
Full year 2025 earnings: EPS and revenues exceed analyst expectations Full year 2025 results: EPS: ₹65.55 (up from ₹52.46 in FY 2024). Revenue: ₹20.4b (up 16% from FY 2024). Net income: ₹2.97b (up 24% from FY 2024). Profit margin: 15% (in line with FY 2024). Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) also surpassed analyst estimates by 3.0%. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth. Declared Dividend • May 19
Dividend of ₹2.00 announced Shareholders will receive a dividend of ₹2.00. Ex-date: 18th July 2025 Payment date: 31st August 2025 Dividend yield will be 0.1%, which is lower than the industry average of 0.8%. Payout Ratios Payout ratio: 3%. Cash payout ratio: 13%. Reported Earnings • May 17
Full year 2025 earnings: EPS and revenues exceed analyst expectations Full year 2025 results: EPS: ₹65.55 (up from ₹52.46 in FY 2024). Revenue: ₹20.7b (up 18% from FY 2024). Net income: ₹2.97b (up 24% from FY 2024). Profit margin: 14% (in line with FY 2024). Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) also surpassed analyst estimates by 3.0%. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 30% per year, which means it is tracking significantly ahead of earnings growth. Announcement • May 17
Dhanuka Agritech Limited announces Annual dividend, payable on August 31, 2025 Dhanuka Agritech Limited announced Annual dividend of INR 2.0000 per share payable on August 31, 2025, ex-date on July 18, 2025 and record date on July 18, 2025. Announcement • May 16
Dhanuka Agritech Limited, Annual General Meeting, Aug 01, 2025 Dhanuka Agritech Limited, Annual General Meeting, Aug 01, 2025, at 11:00 Indian Standard Time. Valuation Update With 7 Day Price Move • May 15
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹1,452, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 102% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹821 per share. Announcement • May 10
Dhanuka Agritech Limited to Report Q4, 2025 Results on May 16, 2025 Dhanuka Agritech Limited announced that they will report Q4, 2025 results on May 16, 2025 Reported Earnings • Feb 04
Third quarter 2025 earnings released: EPS: ₹12.25 (vs ₹9.95 in 3Q 2024) Third quarter 2025 results: EPS: ₹12.25 (up from ₹9.95 in 3Q 2024). Revenue: ₹4.45b (up 10% from 3Q 2024). Net income: ₹550.4m (up 21% from 3Q 2024). Profit margin: 12% (up from 11% in 3Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 21% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Jan 28
Dhanuka Agritech Limited to Report Q3, 2025 Results on Feb 03, 2025 Dhanuka Agritech Limited announced that they will report Q3, 2025 results on Feb 03, 2025 Announcement • Nov 27
Dhanuka Agritech Limited Announces Resignation of Ajeet Singh Tomar as President-Research & Development Dhanuka Agritech Limited announced that Dr. Ajeet Singh Tomar, President-Research & Development of the Company has resigned from the services of the Company on account of personal reasons on the end of the day of 23 November, 2024. Reported Earnings • Nov 07
Second quarter 2025 earnings released: EPS: ₹25.83 (vs ₹22.33 in 2Q 2024) Second quarter 2025 results: EPS: ₹25.83 (up from ₹22.33 in 2Q 2024). Revenue: ₹6.54b (up 5.9% from 2Q 2024). Net income: ₹1.18b (up 16% from 2Q 2024). Profit margin: 18% (up from 17% in 2Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Oct 31
Dhanuka Agritech Limited to Report Q2, 2025 Results on Nov 06, 2024 Dhanuka Agritech Limited announced that they will report Q2, 2025 results on Nov 06, 2024 Price Target Changed • Aug 03
Price target increased by 10% to ₹1,526 Up from ₹1,384, the current price target is an average from 9 analysts. New target price is 16% below last closing price of ₹1,821. Stock is up 137% over the past year. The company is forecast to post earnings per share of ₹62.24 for next year compared to ₹52.46 last year. Announcement • Aug 02
Dhanuka Agritech Limited Announces Resignation of Ram Gopal Agarwal as Chairman & Whole-Time Director Dhanuka Agritech Limited announced resignation of Mr. Ram Gopal Agarwal (DIN: 00627386), Chairman & Whole-time Director of the Company, has submitted his resignation letter dated August 02, 2024 from the office of Chairman and Whole-time Director of the Company with effect from the close of business hours of August 02, 2024. In the annexed letter he stated that he has attained the age of 75 years, also confirmed that the resignation is under succession planning and there is no other material reason for resignation other than mentioned in the letter. Announcement • Jul 26
Dhanuka Agritech Limited to Report Q1, 2025 Results on Aug 02, 2024 Dhanuka Agritech Limited announced that they will report Q1, 2025 results on Aug 02, 2024 Reported Earnings • Jul 12
Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2024 results: EPS: ₹52.46 (up from ₹50.35 in FY 2023). Revenue: ₹17.6b (up 3.4% from FY 2023). Net income: ₹2.39b (up 2.4% from FY 2023). Profit margin: 14% (in line with FY 2023). Revenue missed analyst estimates by 3.0%. Earnings per share (EPS) exceeded analyst estimates by 1.0%. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 19% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jun 10
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹1,522, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 60% over the past three years. Price Target Changed • May 21
Price target increased by 8.2% to ₹1,302 Up from ₹1,204, the current price target is an average from 10 analysts. New target price is approximately in line with last closing price of ₹1,242. Stock is up 83% over the past year. The company is forecast to post earnings per share of ₹60.02 for next year compared to ₹52.46 last year. Declared Dividend • May 20
Final dividend of ₹6.00 announced Shareholders will receive a dividend of ₹6.00. Ex-date: 19th July 2024 Payment date: 1st September 2024 Dividend yield will be 1.1%, which is higher than the industry average of 0.8%. Sustainability & Growth Dividend is covered by both earnings (4% earnings payout ratio) and cash flows (81% cash payout ratio). The dividend has increased by an average of 9.3% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 34% over the next 2 years, which should provide support to the dividend and adequate earnings cover. Announcement • May 19
Dhanuka Agritech Limited, Annual General Meeting, Aug 02, 2024 Dhanuka Agritech Limited, Annual General Meeting, Aug 02, 2024, at 11:00 Indian Standard Time. Reported Earnings • May 18
Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2024 results: EPS: ₹52.46 (up from ₹50.35 in FY 2023). Revenue: ₹17.9b (up 5.5% from FY 2023). Net income: ₹2.39b (up 2.4% from FY 2023). Profit margin: 13% (in line with FY 2023). Revenue missed analyst estimates by 3.0%. Earnings per share (EPS) exceeded analyst estimates by 1.0%. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 14% per year, which means it is tracking significantly ahead of earnings growth. Announcement • May 11
Dhanuka Agritech Limited to Report Q4, 2024 Results on May 17, 2024 Dhanuka Agritech Limited announced that they will report Q4, 2024 results on May 17, 2024 Upcoming Dividend • Feb 07
Upcoming dividend of ₹8.00 per share at 0.8% yield Eligible shareholders must have bought the stock before 14 February 2024. Payment date: 03 March 2024. Payout ratio is a comfortable 4.0% and this is well supported by cash flows. Trailing yield: 0.8%. Lower than top quartile of Indian dividend payers (1.1%). In line with average of industry peers (0.8%). Price Target Changed • Feb 05
Price target increased by 7.1% to ₹1,151 Up from ₹1,075, the current price target is an average from 10 analysts. New target price is 9.8% above last closing price of ₹1,049. Stock is up 55% over the past year. The company is forecast to post earnings per share of ₹52.37 for next year compared to ₹50.35 last year. Reported Earnings • Feb 03
Third quarter 2024 earnings released: EPS: ₹9.95 (vs ₹9.89 in 3Q 2023) Third quarter 2024 results: EPS: ₹9.95. Revenue: ₹4.11b (up 4.4% from 3Q 2023). Net income: ₹453.7m (down 1.5% from 3Q 2023). Profit margin: 11% (in line with 3Q 2023). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Announcement • Feb 02
Dhanuka Agritech Limited Approves Payment of Interim Dividend for the Financial Year 2023-24 Dhanuka Agritech Limited at its Board meeting held on February 2, 2024 approved payment of Interim Dividend @400% i.e INR 8/- per Equity Share of INR 2/- each to the Members of the Company. The Board of Directors has fixed February 14, 2024 as Record Date for the purpose of determining the names of the Members to whom the Interim dividend for the Financial Year 2023-24 will be paid, The payment of Interim Dividend will be completed on or before 30 days from the date of declaration. Announcement • Jan 25
Dhanuka Agritech Limited to Report Q3, 2024 Results on Feb 02, 2024 Dhanuka Agritech Limited announced that they will report Q3, 2024 results on Feb 02, 2024 Reported Earnings • Nov 09
Second quarter 2024 earnings released: EPS: ₹22.33 (vs ₹15.68 in 2Q 2023) Second quarter 2024 results: EPS: ₹22.33 (up from ₹15.68 in 2Q 2023). Revenue: ₹6.18b (up 14% from 2Q 2023). Net income: ₹1.02b (up 39% from 2Q 2023). Profit margin: 17% (up from 14% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 6% per year. Price Target Changed • Nov 09
Price target increased by 7.9% to ₹1,015 Up from ₹941, the current price target is an average from 9 analysts. New target price is 22% above last closing price of ₹833. Stock is up 15% over the past year. The company is forecast to post earnings per share of ₹53.87 for next year compared to ₹50.35 last year. Announcement • Nov 08
Dhanuka Agritech Limited Announces Directorate Changes Dhanuka Agritech Limited announced that at the board meeting held on November 7, 2023 approved the Resignation of Mr. Mridul Dhanuka from the Directorship as Non- Executive and Non-Independent Director of the Company with effect from the closure of business hours of November 7, 2023 and approved the Appointment of Mr. Manish Dhanuka as Non-Executive and Non- Independent Director of the Company. Age is 56 Years. Qualification: B.Tech in Chemical Engineering from IIT, New Delhi, and M.S. in Chemical Engineering from the University of Akron, USA. Experience (Including expertise in the specific functional area)/Brief Resume: He has wide-ranging experience in handling operations, commercial, marketing and finance in the manufacturing industry. He excels in creating economical pharmaceutical technologies and accelerated evaluation processes for improving healthcare. He has experience of 25 years in research, evaluation, and teaching in the pharmaceutical industry equips him with expertise in innovative pharmaceutical technologies. He holds B.Tech in Chemical Engineering from IIT, New Delhi, and M.S. in Chemical Engineering from the University of Akron, USA. He is on the Board of M/s. Dhanuka Laboratories Ltd, M/s. Orchid Pharma Limited, M/s. Orchid Bio-pharma Limited, M/s. Otsuka Chemical (India) Private Limited and M/s. Synmedic Private Limited. Before establishing M/s. Dhanuka Laboratories Ltd. in 1993, he began his career at M/s. Ranbaxy Labs Ltd. in New Delhi and worked there for 5 years. His vision and strategy to grow the pharmaceutical industry in the Indian sub-continent, have helped the Dhanuka Group of Companies to enhance its Bulk Drugs manufacturing arm exponentially. He spearheaded the acquisition of M/s. Synmedic Laboratories in the year 2013 which is involved in pharmaceutical formulations. This entrepreneurial vigor enabled him to take over the operations of M/s. Orchid Pharma Ltd. in March 2020. List of other Public companies in which Directorships held: M/s. Dhanuka Laboratories Limited; M/s. Orchid Pharma Limited and M/s. Orchid-Bio Pharma Limited. Companies (other than Dhanuka Agritech Limited) in which the Director holds directorships and Committee positions in these companies: Managing Director in M/s. Dhanuka Laboratories Limited and M/s. Orchid Pharma Limited Director in M/s. Orchid-Bio Pharma Limited Chairman of Corporate Social Responsibility Committee in M/s. Orchid Pharma Limited Member of Risk Management Committee in M/s. Orchid Pharma Limited. Announcement • Nov 01
Dhanuka Agritech Limited to Report Q2, 2024 Results on Nov 07, 2023 Dhanuka Agritech Limited announced that they will report Q2, 2024 results at 12:15 PM, Indian Standard Time on Nov 07, 2023 Buying Opportunity • Oct 31
Now 21% undervalued Over the last 90 days, the stock is up 6.7%. The fair value is estimated to be ₹1,007, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.9% over the last 3 years. Earnings per share has grown by 7.1%. Revenue is forecast to grow by 18% in a year. Earnings is forecast to grow by 20% in the next year. Announcement • Oct 10
Dhanuka Agritech Limited Announces New Product Launch Dhanuka Agritech Limited announced New Product launch: Semacia is a broad-spectrum insecticide, with excellent efficacy against lepidopteran insect pests on a range of crops. Specification: Insecticide with combination of Chloratranilprole (10%)+ Lambdacyhalothrin (5%) ZC. Announcement • Sep 05
Dhanuka Agritech Limited Announces New Product Launch Dhanuka Agritech Limited announced New Product launch: Name, of Category of the Product, Specification, Whether, caters; Name, of, the, Product, to, domestic/countries, in, international which the market product is launched (in case of international). TIZOM, Herbicide for sugarcane; Herbicide, for domestic, NA, crop having an effective sugarcane, with Market, control, on Broad, leaf; Halosulfuron, weeds; Narrow, leaf; Methyl, weeds & Sedges, 6% +Metribuzin, 50%, WG. Announcement • Jul 28
Dhanuka Agritech Limited to Report Q1, 2024 Results on Aug 02, 2023 Dhanuka Agritech Limited announced that they will report Q1, 2024 results at 12:15 PM, Indian Standard Time on Aug 02, 2023 Reported Earnings • Jul 15
Full year 2023 earnings: EPS and revenues exceed analyst expectations Full year 2023 results: EPS: ₹50.35 (up from ₹44.85 in FY 2022). Revenue: ₹17.0b (up 15% from FY 2022). Net income: ₹2.34b (up 12% from FY 2022). Profit margin: 14% (in line with FY 2022). Revenue exceeded analyst estimates by 1.8%. Earnings per share (EPS) also surpassed analyst estimates by 4.2%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 9.9% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Upcoming Dividend • Jul 14
Upcoming dividend of ₹2.00 per share at 0.3% yield Eligible shareholders must have bought the stock before 21 July 2023. Payment date: 01 September 2023. Payout ratio is a comfortable 4.0% but the company is paying out more than the cash it is generating. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.5%). Lower than average of industry peers (0.9%). Announcement • Jul 11
Dhanuka Agritech Limited Recommends Dividend for the Financial Year Ended 31 March, 2023 The board of directors of Dhanuka Agritech Limited in their meeting held on May 25, 2023, recommended Dividend at 100% INR 2 per equity share having face value of INR 2 per equity share Financial Year ended 31st March, 2023, absorbing INR 91,156,648 subject to the approval of Members at the 38th Annual General Meeting of the Company with a Record date on 21st July 2023. Announcement • Jun 05
Dhanuka Agritech Limited Announces New Product Launch Dhanuka Agritech Limited announced the launch of NEMATAXE, Biological Insecticide. Specification:- Beneficial Nematophagous Fungus: paecilomyces lilacinus (Strain No. P1-1- MTCC 5175). Reported Earnings • May 26
Full year 2023 earnings: EPS and revenues exceed analyst expectations Full year 2023 results: EPS: ₹50.35 (up from ₹44.85 in FY 2022). Revenue: ₹17.4b (up 18% from FY 2022). Net income: ₹2.34b (up 12% from FY 2022). Profit margin: 13% (in line with FY 2022). Revenue exceeded analyst estimates by 1.6%. Earnings per share (EPS) also surpassed analyst estimates by 4.5%. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 7% per year. Announcement • May 24
Dhanuka Agritech Limited Announces New Product Launch Dhanuka Agritech Limited announced new product launch: Implode: Herbicide for Maize and Corn effective on narrow and broad leaf weeds. Mesotrax: Herbicide for Maize and sugarcane effective on narrow and broad leaf weeds. Downil: Biological fungicide effective to control targeted diseases. Spornil: Biological Wilticide effective to control targeted pests. Whiteaxe: Biological Insecticide effective on targeted pests. Announcement • May 19
Dhanuka Agritech Limited to Report Q4, 2023 Results on May 25, 2023 Dhanuka Agritech Limited announced that they will report Q4, 2023 results at 12:15 PM, Indian Standard Time on May 25, 2023 Reported Earnings • Feb 12
Third quarter 2023 earnings released: EPS: ₹9.89 (vs ₹9.13 in 3Q 2022) Third quarter 2023 results: EPS: ₹9.89 (up from ₹9.13 in 3Q 2022). Revenue: ₹3.93b (up 10% from 3Q 2022). Net income: ₹460.7m (up 8.4% from 3Q 2022). Profit margin: 12% (in line with 3Q 2022). Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Announcement • Jan 28
Dhanuka Agritech Limited to Report Q3, 2023 Results on Feb 03, 2023 Dhanuka Agritech Limited announced that they will report Q3, 2023 results at 12:15 PM, Indian Standard Time on Feb 03, 2023 Reported Earnings • Nov 02
Second quarter 2023 earnings released: EPS: ₹15.68 (vs ₹13.61 in 2Q 2022) Second quarter 2023 results: EPS: ₹15.68 (up from ₹13.61 in 2Q 2022). Revenue: ₹5.48b (up 25% from 2Q 2022). Net income: ₹730.2m (up 15% from 2Q 2022). Profit margin: 13% (down from 14% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth. Upcoming Dividend • Jul 14
Upcoming dividend of ₹6.00 per share Eligible shareholders must have bought the stock before 21 July 2022. Payment date: 01 September 2022. Payout ratio is a comfortable 31% but the company is paying out more than the cash it is generating. Trailing yield: 1.7%. Lower than top quartile of Indian dividend payers (1.8%). Higher than average of industry peers (0.8%). Reported Earnings • Jul 13
Full year 2022 earnings: EPS exceeds analyst expectations Full year 2022 results: EPS: ₹44.85. Revenue: ₹14.8b (up 6.5% from FY 2021). Net income: ₹2.09b (flat on FY 2021). Profit margin: 14% (down from 15% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 5.2%. Over the next year, revenue is forecast to grow 11%, compared to a 17% growth forecast for the industry in India. Reported Earnings • May 24
First quarter 2022 earnings released First quarter 2022 results: Revenue: (down 100% from 1Q 2021). Net income: (down ₹486.4m from profit in 1Q 2021). Profit margin: (down from 18% in 1Q 2021). The decrease in margin was driven by lower expenses. Over the next year, revenue is forecast to grow 7.9%, compared to a 17% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 24% per year and the company’s share price has also increased by 24% per year. Reported Earnings • Feb 03
Third quarter 2022 earnings: EPS and revenues exceed analyst expectations Third quarter 2022 results: EPS: ₹9.13 (up from ₹8.54 in 3Q 2021). Revenue: ₹3.64b (up 23% from 3Q 2021). Net income: ₹425.2m (up 6.2% from 3Q 2021). Profit margin: 12% (down from 14% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 5.0%. Earnings per share (EPS) also surpassed analyst estimates by 2.6%. Over the next year, revenue is forecast to grow 12%, compared to a 20% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 26% per year whereas the company’s share price has increased by 24% per year. Price Target Changed • Dec 27
Price target decreased to ₹928 Down from ₹1,000, the current price target is an average from 6 analysts. New target price is 28% above last closing price of ₹726. Stock is down 11% over the past year. The company is forecast to post earnings per share of ₹45.15 for next year compared to ₹44.61 last year. Reported Earnings • Nov 01
Second quarter 2022 earnings released: EPS ₹13.61 (vs ₹14.73 in 2Q 2021) The company reported a poor second quarter result with weaker earnings and profit margins, although revenues were flat. Second quarter 2022 results: Revenue: ₹4.39b (flat on 2Q 2021). Net income: ₹633.8m (down 9.6% from 2Q 2021). Profit margin: 14% (down from 16% in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 26% per year whereas the company’s share price has increased by 24% per year. 
